Abstract: The present invention relates to a sulfonated polystyrene derivative of formula I for use in the treatment and/or prophylaxis of cat flu, especially infection caused by feline calicivirus or feline herpesvirus, alone or in combination therapy.

Abstract: A multifunctional hydrogel hybrid material and a method of its preparation and use in the treatment or prophylaxis of bone tissue loss is disclosed.

Abstract: The subject of the invention is the use of selected polyelectrolytes from the group of synthetic and natural polyelectrolytes for the cryopreservation of human and animal extracellular vesicles. The invention also relates to a method for the cryopreservation of these vesicles, which uses said poly electrolytes.

Abstract: The present invention relates to a sulfonated polystyrene derivative of formula I for use in the treatment and/or prophylaxis of cat flu, especially infection caused by feline calicivirus or feline herpesvirus, alone or in combination therapy.

Abstract: A biocompatible hydrogel hybrid material useful in regenerative medicine, in particular in reconstruction of bone tissue.

Abstract: The subject of the invention is use of block polymers with a block of poly(3-methacryloylpropyltrimethylammonium chloride) to direct neutralization of heparin, especially unfractionated heparin and low molecular weight heparins in the blood and other body fluids.

Abstract: The subject of the invention is use of block polymers with a block of poly(3-methacryloylpropyltrimethylammonium chloride) to direct neutralization of heparin, especially unfractionated heparin and low molecular weight heparins in the blood and other body fluids.

Abstract: The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO3? or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

Abstract: The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO3? or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

Abstract: The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO3? or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

Abstract: The subject of the invention is the use of cationically modified polysaccharides, except for chitosan, for direct neutralization of heparin in blood and physiological fluids in a mammal. Cationic modification of the polysaccharides is achieved using compound containing cationic ammonium groups and/or the polysaccharides are grafted with a polymer containing amine and/or ammonium groups.

Abstract: The use of chitosan polymers of formula I, wherein R is selected from H, COCH3 (HTCC) or from H, COCH3, C12H25 (HM-HTCC) in the treatment and prevention of infections caused by coronaviruses.

Abstract: The subject of the invention is a hybrid photocatalyst which is a layered aluminosilicate, possibly organically modified, containing compounds introduced into the aluminosilicate galleries bearing groups such as porphyrin, rose bengal, anthracene, pyrene, perylene, tetracene, rubrene, naphthalene, phthalocyanines, coumarins, and methylene blue, which are organic chromophores able to absorb visible and/or ultraviolet light and sensitize photochemical reactions. The invention includes also the methods of synthesis and application of the photocatalysts for the photocatalytical degradation of water pollutants.

Abstract: The subject of the invention is the use of cationically modified polysaccharides, except for chitosan, for direct neutralization of heparin in blood and physiological fluids in a mammal. Cationic modification of the polysaccharides is achieved using compound containing cationic ammonium groups and/or the polysaccharides are grafted with a polymer containing amine and/or ammonium groups.

Abstract: The subject of the invention is a hybrid photocatalyst which is a layered aluminosilicate, possibly organically modified, containing compounds introduced into the aluminosilicate galleries bearing groups such as porphyrin, rose bengal, anthracene, pyrene, perylene, tetracene, rubrene, naphthalene, phthalocyanines, coumarins, and methylene blue, which are organic chromophores able to absorb visible and/or ultraviolet light and sensitize photochemical reactions. The invention includes also the methods of synthesis and application of the photocatalysts for the photocatalytical degradation of water pollutants.

Abstract: Use of a chitosan polymer for direct neutralization of heparin in blood and physiological fluids of mammals. The chitosan polymer may be applied as an intravenous solution or for neutralization of heparin in blood or other physiological fluid taken from a donor.

Abstract: Novel antenna polymers characterized by a polymeric background of a biodegradable water soluble polymer and chromophores chemically bonded to the polymeric background have been found to be useful as photocatalysts in aqueous media. On completion of the desired photochemical reaction, the residual medium can safely be discharged to the natural environment as the catalyst residues undergo biodegradation to form environmentally harmless products.

Abstract: Novel antenna polymers characterized by a polymeric background of a biodegradable water soluble polymer and chromophores chemically bonded to the polymeric background have been found to be useful as photocatalysts in aqueous media. On completion of the desired photochemical reaction, the residual medium can safely be discharged to the natural environment as the catalyst residues undergo biodegradation to form environmentally harmless products.